Pseudoprogression Possible in Enzalutamide-Treated mCRPC – Renal and Urology News
In mCRPC, pseudoprogression or bone scan flare can be misinterpreted as enzalutamide failure and lead to premature discontinuation of therapy.
Related Articles
Monogenic Lupus Nephritis Signals Earlier Onset and Worse Renal Outcomes – Renal and Urology News
A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease.
Renal Hyperfiltration Trajectory Tied With Risk of ESKD, Cardiovascular Events, and Death – Renal and Urology News
Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.
Spironolactone Does Not Lower CV Mortality, HF Hospitalization Risk in Patients on Dialysis – Renal and Urology News
Although spironolactone is very effective in patients that do not require dialysis, investigators tested whether spironolactone is effective in patients on dialysis in a phase…
Acellular Tissue Engineered Vessel Maintains Hemodialysis Patency Better Than AVF in High-Risk Patients
Investigators successfully tested an acellular tissue engineered vessel for hemodialysis vascular access in patients at high-risk for arteriovenous fistula (AVF) maturation failure.
Inhibiting Factor XI Does Not Decrease Arteriovenous Graft Thrombosis Rate in Hemodialysis – Renal and Urology News
Investigators evaluated the efficacy and safety of different doses of MK-2060, a monoclonal antibody against Factor XI, to prevent vascular access clotting in patients receiving…
Survival Advantage From Kidney Transplantation vs Dialysis Varies Among Patients – Renal and Urology News
Study is based on registry data from over 64,000 patients with kidney failure across Europe.
Recovery of Erectile Function in Men Undergoing Prostatectomy Tied With Surgeon Performance
Investigators assessed which aspects of surgical performance during radical prostatectomy improve the chances of good functional outcomes.
KRT Risk Lower With SGLT2 Inhibitor vs GLP-1 Receptor Agonist Use in Diabetic CKD
Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.
Even “Low-Risk” Proteinuria Portends Adverse Kidney Outcomes in IgA Nephropathy
Patients with IgA nephropathy may experience faster disease progression than previously appreciated.
Tacrolimus Superior to MMF for Pediatric Relapsing or Steroid-Dependent Nephrotic Syndrome
A randomized clinical trial directly compared the therapeutic benefits and safety profiles of tacrolimus and mycophenolate mofetil in children with nephrotic syndrome.